FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions
- Read more about FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions
- Log in or register to post comments
The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.
Keywords
